Steven Girgenti - Jan 31, 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Executive Chairman, Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Stock symbol
BIAF
Transactions as of
Jan 31, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 04:20 PM
Previous filing
Jan 24, 2024
Next filing
Mar 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +11.9K +1.27% $0.00 952K Jan 31, 2024 Direct F1
holding BIAF Common Stock 8.96K Jan 31, 2024 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024.
F2 These shares owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.